Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RSLS

ReShape Lifesciences (RSLS) Stock Price, News & Analysis

ReShape Lifesciences logo

About ReShape Lifesciences Stock (NASDAQ:RSLS)

Key Stats

Today's Range
$2.80
$4.65
50-Day Range
$3.16
$15.68
52-Week Range
$1.87
$303.25
Volume
13.69 million shs
Average Volume
3.32 million shs
Market Capitalization
$8.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RSLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReShape Lifesciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RSLS Stock News Headlines

Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
3 Penny Stocks to Watch Now, 8/14/25
See More Headlines

RSLS Stock Analysis - Frequently Asked Questions

ReShape Lifesciences Inc. (NASDAQ:RSLS) posted its quarterly earnings results on Thursday, August, 14th. The medical device company reported ($9.00) earnings per share (EPS) for the quarter. The medical device company earned $1.24 million during the quarter. ReShape Lifesciences had a negative net margin of 69.71% and a negative trailing twelve-month return on equity of 547.65%.

ReShape Lifesciences shares reverse split on the morning of Monday, August 18th 2025.The 1-4 reverse split was announced on Wednesday, August 13th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that ReShape Lifesciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Digital Turbine (APPS), Nano Dimension (NNDM), CrowdStrike (CRWD) and

Company Calendar

Last Earnings
8/14/2025
Today
9/19/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:RSLS
CIK
1371217
Fax
N/A
Employees
50
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
($108.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.13 million
Net Margins
-69.71%
Pretax Margin
-47.82%
Return on Equity
-547.65%
Return on Assets
-79.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.53
Quick Ratio
0.91

Sales & Book Value

Annual Sales
$8.01 million
Price / Sales
1.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($8.66) per share
Price / Book
-0.36

Miscellaneous

Outstanding Shares
2,690,000
Free Float
2,386,000
Market Cap
$8.49 million
Optionable
Not Optionable
Beta
1.16

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:RSLS) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners